Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Arch Biochem Biophys. 2021 May 12;705:108917. doi: 10.1016/j.abb.2021.108917

Diversity of Structures and Functions of Oxo-bridged Non-heme Diiron Proteins

Maria Luiza Caldas Nogueira 1, Anthony J Pastore 1, Victor L Davidson 1,*
PMCID: PMC8165033  NIHMSID: NIHMS1705309  PMID: 33991497

Abstract

Oxo-bridged diiron proteins are a distinct class of non-heme iron proteins. Their active sites are composed of two irons that are coordinated by amino acid side chains, and a bridging oxygen that interacts with each iron. These proteins are members of the ferritin superfamily and share the structural feature of a four α-helix bundle that provides the residues that coordinate the irons. The different proteins also display a wide range of structures and functions. A prototype of this family is hemerythrin, which functions as an oxygen transporter. Several other hemerythrin-like proteins have been described with a diversity of functions including oxygen and iron sensing, and catalytic activities. Rubrerythrins react with hydrogen peroxide and rubrerythrin-like proteins possess a rubredoxin domain, in addition to the oxo-bridged diiron center. Other redox enzymes with oxo-bridged irons include flavodiiron proteins that act as O2 or NO reductases, ribonucleotide reductase and methane monooxygenase. Ferritins have an oxo-bridged diiron in the ferroxidase center of the protein, which plays a role in the iron storage function of these proteins. There are also bacterial ferritins that exhibit catalytic activities. The structures and functions of this broad class of oxo-bridged diiron proteins are described and compared in this review.

Keywords: hemerythrin, ferritin, flavodiiron protein, methane monooxygenase, ribonucleotide reductase, rubrerythrin

1. Introduction

It has been estimated that as many as half of all proteins contain a metal [1, 2]. Iron is a common component of metalloproteins that allows the protein to perform a variety of functions. Iron is a component of the heme cofactor that is used to store and transport oxygen as in hemoglobin. Iron in c-type hemes typically functions in electron transfer through and between proteins. Iron in b-type hemes can be used to activate oxygen during catalysis, as in oxidases and oxygenases. Iron-sulfur centers also participate in electron transfer reactions. Non-heme iron is utilized by proteins for catalysis and electron transfer.

This review focusses on a functionally diverse and expanding class of metalloproteins that have two non-heme iron ions with a bridging oxygen atom. The chemical state of the bridging oxygen is typically O, which may be protonated or hydrogen bonded depending upon the environment in the protein and redox state of the irons. However, in this diverse group of proteins other states, such as H2O and peroxy are observed. It is generally believed that the assembly of the oxo-bridged diiron sites do not require accessory proteins but are self-assembled. A prototype of the oxo-bridged diiron protein is hemerythrin [3, 4]. The source of the bridging oxygen is water [3]. True hemerythrins bind O2 at one of the irons and function as oxygen transporters. Several other types of hemerythrin-like proteins have been described with other functions that include iron or O2 sensing, iron-sulfur center repair, NO reductase activity and catalase activity [5, 6]. Rubrerythrins use the oxo-bridged diiron for oxidative stress tolerance [7]. Other identified enzymes that utilize an oxo-bridged diiron at their active sites include flavodiiron proteins that reduce NO or O2 [8], ribonucleotide reductase [9] and methane monooxygenase [10]. All of these oxo-bridged diiron proteins are considered part of the ferritin superfamily. Ferritins have oxo-bridged diiron centers that can function in iron storage, prevention of oxidative damage to nucleic acids and catalase activity [11, 12]. All of these oxo-bridged diiron proteins share a common structural fold, a 4 α-helix bundle that houses the diiron site. However, the overall structures can be quite different and the identity of the ligands that coordinate the irons varies. Oxo-bridged diiron proteins are found in prokaryotes, eukaryotes and archaea. Many of the members of this broad group of proteins have been reviewed individually. This review compares and contrasts the structures of the diiron sites and overall structures of these proteins, and highlights the diversity of their functions.

2. Hemerythrin and Hemerythrin-like proteins (HLPs)

2.1. True hemerythrins

The first protein to be structurally characterized and shown to possess an oxo-bridged diiron center is hemerythrin [13]. True hemerythrins were first described in marine invertebrates, and subsequently numerous hemerythrin-like proteins (HLPs) that contain an analogous oxo-bridged diiron center were described in a wide range of prokaryotic and eukaryotic species [5]. Hemerythrins do not contain heme, but use oxo-bridged non-heme irons for oxygen transport or storage [3]. Hemerythrins have a core structure composed of a four right-handed α-helix bundle fold that houses the diiron site with the bridging oxygen. These proteins are typically comprised of six or eight identical subunits, as observed in the Phascolopsis gouldii crystal structure [14] shown on Figure 1A. However, monomeric hemerythrins have also been characterized from Methylococcus capsulatus (Bath) [15] (Fig. 1B), and the peanut worm Themiste hennahi [16]. In hemerythrins, the two oxo-bridged irons are coordinated by seven amino acid residues: five His, one Glu and one Asp, as shown in Figure 1C.

Figure 1. A.

Figure 1.

A. Structure of the octomeric hemerythrin from Phascolopsis gouldii (PDB entry 1I4Y) [14]. B. Structure of the canonical four 〈-helix bundle of the monomeric hemerythrin from M. capsulatus (Bath) (PDB entry 4XPX) [15]. The two irons shown as brown spheres. C. The oxo-bridged diiron center of M. capsulatus hemerythrin (PDB entry 4XPX) [15]. Amino acid residues that coordinate irons (brown spheres) are shown as sticks, and the bridging oxygen is shown as a red sphere. Figures were prepared using PyMOL [17].

Spectroscopic and redox studies of the monomeric hemerythrin from M. capsulatus (Bath) characterized three different oxidation states of the diiron center (Figure 2). The oxy form is Fe+3-Fe+3 with O2 bound to iron. The terminal O typically reacts with a hydrogen and becomes a hydroperoxyl ligand that can hydrogen bond with the bridging oxygen. The deoxy form is Fe+2-Fe+2. The oxy and deoxy forms can directly interconvert by dioxygen release or incorporation. The oxy form may also auto-oxidize in the presence of water to yield the met form, with release of H2O2 [15, 18]. This met form is Fe+3-Fe+3 without bound O2, and it can be reduced to regenerate the deoxy form. The met form can bind ligands other than O2, such as OH, or unnatural ligands such as azide [4, 13].

Figure 2.

Figure 2.

Interconversion of the deoxy, oxy, and met forms of the oxo-bridged diiron center of hemerythrin.

2.2. Hemerythrin-like proteins (HLPs)

Bioinformatics analyses have identified a large number of HLPs in all phylogenetic kingdoms [19]. All HLPs possess oxo-bridged diiron sites within a core structure of four α-helices. The amino acid residues that ligate the two irons in HLPs are similar but with some variation. The sequence of each exhibits the characteristic HHE cation-binding domain seen in true hemerythrins. The residues that provide iron ligands in hemerythrins are in the sequence in the order HHEHHHD, with variable lengths of separation between residues in the sequence motif [3]. Some HLPs possess this same sequence pattern; however, others exhibit HHEYHHE, HHEHHE or HHEEHHE patterns [5, 6] (Figure 3).

Figure 3.

Figure 3.

Examples of the different combinations of amino acid residues that coordinate the irons in hemerythrin-like proteins. A. HLP from Mycobacterium kansasii with 4H/2E/1Y coordination (PDB entry 6Q09) [20]. B. Iron-sulfur center repair HLP, YtfE, from E. coli with 4H/2E coordination (PDB entry 5FNN) [21]. C. Iron sensing FBXL5 HLP from Homo sapiens with 4H/3E coordination (PDB entry 3V5X) [22]. Figures were prepared using PyMOL [17].

The HHEYHHE motif is seen only in HLPs from mycobacterial species [6]. The mycobacterial HLPs are also distinct in possessing a fifth α-helix connected by a short loop to the four-helix core structure that houses the oxo-bridged diiron site. The protein from Mycobacterium tuberculosis is a homodimer [23] and that from Mycobacterium kansasii is a monomer [20]. The M. tuberculosis HLP exhibits catalase activity [23] and the M. kansasii HLP exhibits modest catalase activity and reactivity towards nitric oxide [20].

The HLPs that have been identified from all other sources have very different overall structures. In each, the four α-helical domain is fused to another protein domain that dictates the biological function of the HLP. These functions include signal transduction [24], oxygen sensing [25], iron sensing [26], repair of Fe-S centers from redox damage [21, 27], modulation of the oxidative stress response [28], and storage and transport of iron [29]. HLPs have also been linked to antimicrobial [30] and antiviral activity [31], and immune response in some organisms [32]. The function of many HLPs is linked to other proteins domains of known function. Some examples are as follows. The F-BoX and Leucine-rich repeat 5 (FBXL5) protein domain is associated with some HLPs that function as iron sensors, in which the oxo-bridged diiron structure destabilizes under iron depletion [33]. The F-BoX domain is part of the E3 ubiquitin ligase complex that targets iron regulated protein 2 (IRP2) for degradation, which is delayed under hypoxic conditions [34]. The FBXL5 domain of an HLP also binds the Rho GDP inhibitor 2 (RhoGD2) and attenuates the resistance for the antineoplastic drug cisplatin, and therefore is a potential target to treat this gastric cancer cell resistance [35]. An HLP was described with an additional domain that has cyclic-di-GMP phosphodiesterase activity [28] that is suggested to be an oxygen and redox sensor that modulates cellular GMP levels [28]. An HLP was described that has iron-dependent DNAse activity and is possibly related to DNA damage induced by oxidative stress [36].

3. Rubrerythrin and rubrerythrin-like proteins

The name rubrerythrin stems from the fact that canonical rubrerythrins possess a C-terminal rubredoxin domain and N-terminal domain that is similar to that of hemerythrin, with an oxo-bridged diiron center (Figure 4A). The rubredoxin domain is smaller than the hemerythrin domain. It is similar to the rubredoxin as it contains an Fe-4Cys center, in which an iron is coordinated by four sulfur ligands provided by the four Cys residues [37] (Figure 4B). The oxo-bridged diiron center in the hemerythrin domain is coordinated by Glu residues and a single His residue (Figure 4C). In each domain, the irons are ferrous under physiological conditions [38].

Figure 4.

Figure 4.

Structural features of the rubrerythrin from D. vulgaris. A. The rubrerythrin monomer with the hemerythrin-like domain is pale cyan and the rubredoxin-like domain is light blue. B. The Fe-4Cys rubredoxin-like site. C. The hemerythrin-like diiron center. The Fe, N, O and S atoms are colored brown, blue, red and yellow, respectively. The figures were prepared with PyMOL [17] using PDB entry 1RYT [37].

The rubrerythrin isolated from D. vulgaris is a dimer in solution [39]. The hemerythrin-like domains of rubrerythrins possess a twisted left-hand 4-helix bundle fold (Figure 4A). As shown in the structure of the Pyrococcus furiosus rubrerythrin (Figure 5), the protein is a head-to-tail homodimer. What this means is that the rubredoxin-like domain from one monomer (“head’) interacts with the hemerythrin-like domain on the other monomer (“tail”). In the hemerythrin-like domain, each monomer contributes two helices to form the 4-helix bundle that surrounds the diiron site [37, 40] (Figure 5). In contrast to true hemerythrins, the hemerythrin-like domains of rubrerythrins have greater solvent accessibility and do not use O2 as an oxidant [37, 41].

Figure 5.

Figure 5.

Dimeric structure of rubrerythrin from P. furiosus. Each monomer is colored gray or cyan. Irons are shown as brown spheres. The figure was prepared with PyMOL [17] using PDB entry 3PWF [40].

Rubrerythrins are scavengers of H2O2 that play a role in oxidative stress defense. Rubrerythrin homologues are found in protozoa, bacteria [42] and archaea [40]. The proteins are classified in five groups, in part on their evolutionary relationship. Groups 1, 2 and 3 proteins are present in obligate anaerobes. Group 4 proteins are present in facultative aerobes. Group 5 proteins are present in cyanobacteria [7]. Most of the canonical rubrerythrins belong to Group 1. Many of those in Group 2 are termed “reverse-type rubrerythrins” because the order of their rubredoxin and hemerythrin domains is reversed. In other words, these proteins have an N-terminal rubredoxin domain and C-terminal hemerythrin domain. All members of group 4, and about 15% and 40% percent of the groups 2 and 5, respectively, lack their rubredoxin-like domain.

The substrate for rubrerythrins is H2O2. In many anaerobic hosts the H2O2 is generated by superoxide reductases [43]. Rubrerythrin converts the H2O2 to water by a two-electron reduction [44]. This is an important mechanism in microbes that do not express superoxide dismutases to prevent oxidative damage [45]. A reaction mechanism for rubrerythrin has been proposed that is based on structural differences between the oxidized, reduced, and adduct-intermediate forms of the enzyme. The rubredoxin-like domain obtains electrons from an external reductant. For some rubrerythrins, the electron donor is NAD(P)H [44, 46] (Eq. 1). This is followed by two one-electron transfers from the Fe-4Cys center to the diferric diiron center. The resultant diferrous center then binds H2O2 which bridges the two irons to form a μ−1,2-H2O2 intermediate that is converted to two equivalents of water [44, 46]. When the protein is reduced to the diferrous state, a Glu residue that coordinates one of the irons shifts its position and hydrogen bonds with solvent. A His residue replaces the Glu as an iron ligand. This new geometry of the diiron center enables the reduction of H2O2 [40, 41]. This process is reversed with return of the Glu ligand when the irons return to the diferric state [40, 44, 47].

NAD(P)H+H++H2O2NAD(P)++2H2O (1)

4. Redox Enzymes

4.1. Flavodiiron proteins

Flavodiiron proteins (FDPs) are present throughout nature and typically function as NO or O2 reductases. They are named FDP because they possess an FMN-binding domain and an oxo-bridged diiron site, which resides in a β-lactamase domain. Many FDPs have additional domains with additional functional groups. FDPs are classified as Groups A-H according to the composition of the additional domains [8, 48]. Group A proteins have no additional domain. Group B proteins have a rubredoxin-like domain with a relatively large spacing of amino acid residues between the two Cys-XX-Cys motifs. Group C proteins have an NAD(P)H:flavin oxidoreductase-like (FlvR) domain. Group D proteins have a rubredoxin-like domain with a relatively short amino acid spacing between Cys-XX-Cys motifs. Group E proteins have an iron-sulfur center in addition to three conserved Cys in a CXHX3C-X32CP motif. Group F proteins have an NADH:rubredoxin oxidoreductase-like domain and a rubredoxin-like domain. Group G proteins have an FlvR and a rubredoxin-like domain. Group H proteins have an FlvR and two rubredoxin-like domains.

To provide an example of this diverse group of FDPs, the FlRd protein from E. coli will be described. This protein is a cytoplasmic O2 and NO reductase with a higher affinity for NO [49]. FlRd denotes flavo-rubredoxin as the enzyme contains a rubredoxin-like domain in addition to the FMN binding domain, and an oxo-bridged di-iron site. FlRd acts as a NO scavenger under anaerobic conditions and its expression is upregulated under oxidative stress [50]. FlRd is a homotetramesr in solution, as shown by small angle light scattering [51]. The structure of the protein was solved by a combination of x-ray crystallography and NMR [52]. The irons in the oxo-bridged diiron site are coordinated by four His, two Asp and a Glu that acts as a bridging ligand (Figure 6A).

Figure 6.

Figure 6.

The FlRd FDP from E. coli A. The oxo-bridged diiron site from PDB entry 5LMC [52]. B. Electron transfer path from NADH-reduced FlRd reductase to the oxo-bridged diiron center for reduction of NO. Two electrons are required for the reduction of NO. They are transferred one at a time via the FMN. Figure 6A was prepared using PyMOL [17].

NADH is the source of electrons for the reduction of NO. Electrons are transferred from NADH to the rubredoxin-like domain by a FAD-dependent FlRd reductase, and then to the diiron center via the FMN (Figure 6B). Electrons are transferred one at a time, given evidence of the formation of the FMN semiquinone without detection the hydroquinone form. The diferrous site then reduces NO as shown in Figure 6B, or alternatively can reduce O2 [51, 53].

4.2. Ribonucleotide reductase

Ribonucleotide Reductase (RNR) catalyzes the reduction of ribonucleotides to deoxyribonucleotides (Figure 7A). This is required by all organisms for DNA biosynthesis and repair [9, 54]. RNR is also a target for antineoplastic drugs [55] including gemcitabine [56], clofarabine [57], cladribine and fludarabine [58]. RNRs are divided into three classes: I, II and III. The class I RNRs, which are the most studied group of enzymes, are further classified as Ia, Ib and Ic. These three classes are differentiated, in part, by the type of metal center used for catalysis. The class Ia enzymes utilize an oxo-bridged diiron center.

Figure 7. A.

Figure 7.

A. Substrate and product of the reaction catalyzed by ribonucleotide reductase. The R group represents the nitrogen base from adenine, cytosine, guanine, or uracil. B. The diiron site in the R2 subunit of the E. coli class ribonucleotide reductase from PDB entry 1MXR [59]. The Fe, N and O atoms are colored brown, blue and red, respectively. Figure7B was prepared using PyMOL [17].

The class I RNRs are α2β2 heterodimers. The α subunits, which are named R1, contain the catalytic ribonucleotide reduction site and binding sites for allosteric regulation. The β subunits, which are named R2, house the diiron sites and a critical Tyr residue that functions in a diferric tyrosyl radical complex. This species is the starting point for a long-range electron/radical transfer pathway to oxidize an active-site Cys to initiate catalysis. The oxo-bridged irons are coordinated by two His, three Glu and an Asp (Figure 7B). The diiron site is packed within a typical 4-helix bundle, as well as several additional α-helices (Figure 8), which distinguishes this protein from most other oxo-bridged diiron proteins [59, 60].

Figure 8.

Figure 8.

Structure of ribonucleotide reductase. Two orientations are presented to view α2β2 heterodimer. The R1 dimer subunits are colored gray and light blue. Only one of the α subunits (light blue) makes contact with the R2 dimer subunits (pale-cyan and pale-green). In this structure, the substrate GDP molecule (red) is present on this α subunit. The two diiron sites on each β subunit are shown as brown spheres. This figure was prepared in PyMOL [17] using PDB entry 6W4X [61].

Structural information of the full α2β2 complex has been difficult to obtain by x-ray crystallography because of transient dynamic subunit interactions. This led to uncertainty of the exact mechanism and pathway for the long-range protein coupled electron transfer (PCET) that is required for catalysis. The first holo-complex structure revealed the flexibility of regions involved in this [60]. Recently, the structure of the α2β2 complex was obtained by cryo-electron microscopy of the protein (Figure 8) [61].

In the E. coli enzyme, the PCET is initiated in the diiron site with formation of a tyrosyl radical (FeIII2-122Y•) in the β subunit. The long range PCET processes then generates a Cys thiol radical (439C-S•) in the α subunit active site that reduces the substrate [61]. In the E. coli enzyme structure, the direct distance between the Tyr and Cys in the structure is approximately 33 Å. The PCET pathway via intervening residues is longer. Several studies have implicated the participation of the residues βTyr122, βTyr356, αTyr731, αTyr720, and αCys439 in the PCET, in that order [55, 6163]. A role for βTrp48 has also suggested [64, 65]. The hole transfer to the Cys leads to abstraction of a hydrogen from the ribonucleotide, and a formation of a radical intermediate. This leads to production of the deoxynucleotide product and regeneration of the cysteinyl radical [66]. The regeneration of the initial Tyr radical that is associated with the diiron site is achieved by electron/radical transfer in the reverse direction from the Cys radical.

4.3. Methane Monooxygenase

Two types of methane monooxygenases exist. One is a copper-dependent membrane associated particulate methane monooxygenase. The other is a cytoplasmic soluble methane monooxygenase (sMMO) that utilizes an oxo-bridged diiron center. The sMMO complex contains three components: a hydroxylase (MMOH), a FAD-containing reductase (MMOR) and the regulatory protein MMOB. The structure of the M. capsulatus MMOH crystallizes as an α2β2γ2 dimer, as shown in Figure 9A [67]. The diiron center is in the α subunit within a canonical 4-helix bundle. The irons are coordinated by two His residues and four Glu residues (Figure 9B).

Figure 9.

Figure 9.

The soluble methane monooxygenase from M. capsulatus Bath. A. The overall structure of the enzyme with its subunits α, β and γ colored in cyan, purple, and gray, respectively. B. The oxo-bridged diiron site of MMOH subunit α. The irons colored brown, oxygen red (including a crystallographic water) and nitrogen blue. Figures were prepared with PyMOL [17] using PDB entry 1MMO [67].

The MMOH activity is stimulated by MMOB and inhibited by an additional regulatory protein, MMOD. Electron transfer in MMOR-MMOH is stimulated by the MMOB-MMOH interaction. Methanol inhibits activity allosterically [68]. The MMOB-MMOH binding induces conformational changes in MMOH that facilitates access of its substrates, CH4 and O2, to the active site [69]. The gene that encodes the MMOD inhibitor is located in the sMMO operon. The biding of two MMOD molecules to one MMOH [70] leads to conformational changes in MMOH that disrupt its diiron coordination [71]. The reaction is also affected by the ternary complex formed from MMOH, MMOR, and MMOB, to promote the transfer of two electrons. [69].

MMOH catalyzes the conversion of methane to methanol. Several studies have identified multiple intermediate states of the diiron site that occur during the reaction [10, 7274]. A mechanism for this reaction is shown in Figure 10 that depicts the structures of some of these intermediates to highlight the changes that occur in the oxo-bridged diiron site during the reaction. MMOR reduces MMOH to form a diferrous center as shown in the first step. The reduction is accompanied by a shift in the coordination of carboxylate of one of the Glu ligands from monodentate to bidentate at the diiron center. Binding of O2 is facilitated by the interaction between MMOH and MMOB. The state in which O2 has entered the enzyme prior to interaction with the diiron site is referred to as Intermediate O (not shown). Reaction of O2 with the diiron leads to the formation of Intermediate P with loss of water (Figure 10). The cleavage of the O-O bond of the bridging peroxo group in the diferric Intermediate P, in concert with the oxidation of both irons to the Fe(IV) state leads to formation Intermediate Q. Intermediate Q is the active species and oxidizes methane. Intermediate R (not shown) is formed from hydrogen abstraction from the methane substrate with one of the irons becoming Fe(III). Then methanol is formed using one of the bridging oxygens with the second iron becoming Fe(III). This intermediate with methanol still present in the enzyme is Intermediate T (not shown). The exact in a manner by which this conversion occurs is not well understood. Addition of water and release of methanol reforms the oxidized MMOH.

Figure 10.

Figure 10.

Proposed mechanism of soluble methane monooxygenase.

5. Ferritins

Ferritin (Ftn) is the major protein utilized for iron storage. In doing so, Ftn prevents significant levels of potentially dangerous free iron from accumulating and controls the release of iron when needed. In addition to this important role in iron homeostasis, Ftns and Ftn-like proteins also have roles in detoxification, prevention of oxidative damage, nucleic acid protection, and prevention of nutritional stress [11]. Genetic mutations in the ferritin gene leading to dysfunctional Ftn proteins can cause ferritinopathy and neurodegenerative diseases [75]. Many Ftns self-assemble into 24-subunit oligomers with a hollow inner cage that stores iron atoms (Figure 11A) [76, 77]. This design has been exploited for applications in biotechnology, as a nano-carrier for drug delivery [78] and in biocatalysis [79]. Ftns are present throughout nature in animals and bacteria and share very similar structural features. This section will focus on the human Ftns, and Ftn and Ftn-like proteins from E. coli that exhibit a more diverse range of functions.

Figure 11.

Figure 11.

Human H-type Ferritin. A. Structure of the 24-mer structure with two orientations shown to illustrate the 3-fold and 4-fold pore symmetry highlighted in pale-cyan and light blue respectively (PDB entry 6JPS) [80]. B. The 5-helix subunit with A, B and C irons as spheres (PDB entry 4OYN) [82]. C. The oxo-bridged AB diiron site and C iron site. Residues that coordinate the AB site irons are colored in pale-cyan and those that coordinate the C-site iron in light blue (PDB entry 4OYN). [82]. The Fe, N and O atoms are colored brown, blue and red, respectively. Figures were prepared using PyMOL [17].

5.1. Human Ftn

The structure of Ftn monomers consists of a four left-hand twist α-helix bundle with a centralized oxo-bridged diiron center that is coordinated primarily by His and Glu residues. An additional small fifth α-helix is also present near the C terminal (Figure 11B). There are three types of Ftn monomers that are named according to their relative molecular masses; heavy (H), medium (M) and light (L). Human Ftn is composed of 24 of these monomers [80]. Different Ftns share similar 24-subunit shell-like shapes. Iron ions and solvent transit in and out of the molecule by several channels formed at the interfaces between subunits that exhibit 3-fold and 4-fold symmetry (Figure 12A). Ftn may exist as a heteropolymer of H and L subunits or a homopolymer of either H or M subunits. Human L and H subunits share 53% amino acid sequence identity and a similar fold, with variation only in the turn, between the fourth and the fifth helix [81]. Each of the M and H Ftn subunits has one ferroxidase center, which contains two iron binding sites, termed A and B, that are positioned in the middle of the 4-helix bundle (Figure 11B) [82]. The site A iron is coordinated by two Glu residues, a His and two waters. The B site iron is coordinated by two Glu residues and two waters. One of the Glu residues shares bidentate coordination with the irons in and so is a component of both the A and B sites [82] (Figure 12C). A bridging oxygen can be coordinated by the irons in the A and B site. A diiron oxidizing reaction occurs at the AB site to form ferric iron for storage within the Ftn. The diameter of the polymer inner cavity where iron is stored is approximately 80 Å. The L subunit is distinct from the H and M as it does not have a typical ferroxidase center with an AB site [82]. The L Ftn subunit is found in long-term iron storage tissues and exhibits a significantly slower iron oxidation rate at the mineral core [81]. The ratio of H to L monomers in the HL heteropolymers is variable [8387]. While iron is the physiologically relevant metal, Ftns also have been shown to have affinity for other metals including calcium, cobalt, cooper, magnesium and terbium [88].

Figure 12.

Figure 12.

Bacterial Ftn iron centers. A. The AB diiron site of E. coli Ftn (PDB entry 4ZTT) [94]. B. The AB diiron site and C iron site of P. aeruginosa Ftn with the AB site colored in pale-cyan and C site colored in light blue (PDB entry 3R2L) [91]. The Fe, N and O atoms are colored brown, blue and red, respectively. Figures were prepared using PyMOL [17].

Human H-type Ftn has a third iron site termed the C site, which is approximately 6.5 Å from the B site (PDB 4OYN) (Figure 11C). The C site weakly binds ferrous iron and it thought to mediate the entrance and exit of ferric iron from the AB site [89]. Iron in this third site is coordinated by Tyr34, Gln58 and Glu61 [82]. While the ferrous irons in the AB site are preferentially oxidized by O2, in some situations H2O2 can be used oxidant [90]. Studies of variant proteins with mutations that prevented iron from binding to the C suggested that the C site might act as an AB site modulator that assists in a H2O2 detoxification mechanism [90]. In the human Ftn L subunit, the A and B iron sites are replaced by a mineral core nucleation site, which is pointed to the inner cage surface. This is a trinuclear iron site that is coordinated by Glu residues [81].

5.5. Escherichia coli ferritins

E. coli expresses two Ftns and two Ftn-like proteins. EcFtnA and EcFtnB are archetypal ferritins. EcDps is a DNA-binding protein from cells experiencing starvation. The other is bacteroferritin (EcBfr) [12], which has a b-type heme present in its dimer interface. EcFtnA has only 22% sequence identity to human H-type Ftn, but does share the same overall structure with a 4-helix bundle monomer that assembles into a 24-subunit protein with a hollow shell used for iron storage. It is noteworthy that most of the identical residues are clustered on the center of the 4-helix bundle. The E. coli FtnA also has the AB and C iron sites [90]. In its crystal structure, the iron is observed only in the AB site, which is shown in Figure 12A. However, the three irons in the AB and C site are observed in the crystal structure of the bacterial Ftn from P. aerugiosa (Figure 12B)[91]. EcFtnA lacks a conserved sequence of four Glu residues from the mammalian L subunit that has been associated with the iron core nucleation, however it retains the iron nucleation and its function as an iron storage protein [92]. EcFtnB has low sequence similarity to with FtnA and lacks residues important for fast iron oxidation [93]. Its shares only 25% of primary sequence identity with human Ftn L, and the core mineralization residues of the L-type ferritins are absent in EcFtnB.

EcDps binds DNA and protects it from oxidative stress by neutralizing H2O2. Analogous proteins are found in eubacteria and archaea [95]. It is composed of 12, rather than 24 subunits and is able to store up to 500 irons per molecule shell [96]. In contrast to other Ftns that use O2 as the major electron acceptor, EcDps prefers H2O2 as an oxidant for the ferroxidation and mineralization reactions [97]. In vivo studies showed that a Trp52Ala mutation decreased bacterial resistance to the potentially toxic H2O2 [98]. The lysine enriched N-terminal of EcDps binds to DNA. This allow EcDps to protect DNA from oxidative damage [99, 100]. M. tuberculosis also has a DPS Ftn-like protein that has this activity [101].

The EcBfr has 24 identical H subunits and up to 12 protoporphyrin IX groups, one per dimer interface. A conserved Met binds the b-type heme to the polypeptide (Figure 13A). In addition to the 3- and 4-fold symmetry channels, EcBfr also has another channel named the B-pore. The EcBfr has AB and C sites similar to those described in other ferritins (Figure 13B). Bfrs, which are composed of heterodimers, are also found in Pseudomonas aeruginosa [102] and M. tuberculosis [101]. The BfrA from M. tuberculosis is unique as it has both Dps-like function and catalase activity. The catalase function might counteract the absence of the Dps gene in this bacterium, thus preventing H2O2 oxidative damage [101].

Figure 13.

Figure 13.

Bacterioferritin from E. coli. A. Overall structure of the protein with the subunits of the dimer colored light blue and gray. The irons are shown as spheres and the heme is colored in red. B. Residues that coordinate the AB diiron and the C site. Figures were prepared with PyMOL [17] using PDB entry 3E1M [103].

6. Summary

The oxo-bridged iron proteins described in this review share a common structural fold, a 4 α-helix bundle that houses the oxo-bridged diiron site. However, the overall structures of the different proteins that share this feature can be quite different, and the identity of the ligands that coordinate the irons varies. These proteins exhibit a wide range of functions including iron storage, oxygen transport, sensing and a wide range of catalytic activities employing different reaction mechanisms. Recognition of these types of proteins is growing. This is reflected by the recent increase in identification of a variety of hemerythrin-like proteins with diverse activities, including a distinct subset in mycobacteria. While the structural characterization of these proteins has significantly advanced, much still remains to be determined regarding the precise physiological roles and mechanisms of action of many of the more recently identified proteins.

Acknowledgments

Funding

Research from the authors’ laboratory was provided by the National Institute of General Medical Sciences of the National Institutes of Health under award R35GM130173 (V.L.D.).

Abbreviations:

Bfr

bacterioferritin

HLP

hemerythrin-like protein

FDP

flavodiiron protein

Ftn

ferritin

MMO

methane monooxygenase

PCET

protein coupled electron transfer

RNR

ribonucleotide reductase

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • [1].Lu Y, Yeung N, Sieracki N, Marshall NM, Design of functional metalloproteins, Nature 460 (2009) 855–862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Thomson AJ, Gray HB, Bio-inorganic chemistry, Curr Opin Chem Biol 2 (1998) 155–158. [DOI] [PubMed] [Google Scholar]
  • [3].Stenkamp RE, Dioxygen and hemerythrin, Chem. Rev 94 (1994) 715–726. [Google Scholar]
  • [4].Vincent JB, Olivier-Lilley GL, Averill BA, Proteins containing oxo-bridged dinuclear iron centers: a bioinorganic perspective, Chem Rev 90 (1990) 1447–1467. [Google Scholar]
  • [5].Alvarez-Carreno C, Alva V, Becerra A, Lazcano A, Structure, function and evolution of the hemerythrin-like domain superfamily, Protein Sci 27 (2018) 848–860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Ma Z, Caldas Nogueira ML, Marchi-Salvador DP, Davidson VL, Correlation of conservation of sequence and structures of mycobacterial hemerythrin-like proteins with evolutionary relationship and host pathogenicity, ACS Omega 5 (2020) 23385–23392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Cardenas JP, Quatrini R, Holmes DS, Aerobic lineage of the oxidative stress response protein rubrerythrin emerged in an ancient microaerobic, (hyper)thermophilic environment, Front microbiol 7 (2016) 1822–1822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Romão CV, Vicente JB, Borges PT, Frazão C, Teixeira M, The dual function of flavodiiron proteins: oxygen and/or nitric oxide reductases, J Biol Inorg Chem 21 (2016) 39–52. [DOI] [PubMed] [Google Scholar]
  • [9].Nordlund P, Reichard P, Ribonucleotide reductases, Annu Rev Biochem 75 (2006) 681–706. [DOI] [PubMed] [Google Scholar]
  • [10].Banerjee R, Jones JC, Lipscomb JD, Soluble methane monooxygenase, Annu Rev Biochem 88 (2019) 409–431. [DOI] [PubMed] [Google Scholar]
  • [11].Alejandro Y, The Ferritin Superfamily, in: Harris JR, Marles-Wright J (Eds.), Macromolecular Protein Complexes, Springer International Publishing, Switzerland, 2017, pp. 75–102. [Google Scholar]
  • [12].Andrews SC, The Ferritin-like superfamily: Evolution of the biological iron storeman from a rubrerythrin-like ancestor, Biochim Biophys Acta 1800 (2010) 691–705. [DOI] [PubMed] [Google Scholar]
  • [13].Holmes MA, Stenkamp RE, Structures of met and azidomet hemerythrin at 1.66 A resolution, J Mol Biol 220 (1991) 723–737. [DOI] [PubMed] [Google Scholar]
  • [14].Farmer CS, Kurtz DM Jr., Liu ZJ, Wang BC, Rose J, Ai J, Sanders-Loehr J, The crystal structures of Phascolopsis gouldii wild type and L98Y methemerythrins: structural and functional alterations of the O2 binding pocket, J Biol Inorg Chem 6 (2001) 418–429. [DOI] [PubMed] [Google Scholar]
  • [15].Chen KHC, Chuankhayan P, Wu H-H, Chen C-J, Fukuda M, Yu SSF, Chan SI, The bacteriohemerythrin from Methylococcus capsulatus (Bath): Crystal structures reveal that Leu114 regulates a water tunnel, J Inorg Biochem 150 (2015) 81–89. [DOI] [PubMed] [Google Scholar]
  • [16].Martins LJ, Hill CP, Ellis WR Jr., Structures of wild-type chloromet and L103N hydroxomet Themiste zostericola myohemerythrins at 1.8 A resolution, Biochemistry 36 (1997) 7044–7049. [DOI] [PubMed] [Google Scholar]
  • [17].Schrodinger LLC, The PyMOL Molecular Graphics System, Version 1.8, 2015. [Google Scholar]
  • [18].Kao WC, Wang VC, Huang YC, Yu SS, Chang TC, Chan SI, Isolation, purification and characterization of hemerythrin from Methylococcus capsulatus (Bath), J Inorg Biochem 102 (2008) 1607–1614. [DOI] [PubMed] [Google Scholar]
  • [19].Bailly X, Vanin S, Chabasse C, Mizuguchi K, Vinogradov SN, A phylogenomic profile of hemerythrins, the nonheme diiron binding respiratory proteins, BMC Evol Biol 8 (2008) 244–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Ma Z, Abendroth J, Buchko GW, Rohde KH, Davidson VL, Crystal structure of a hemerythrin-like protein from Mycobacterium kansasii and homology model of the orthologous Rv2633c protein of M. tuberculosis, Biochem. J. 477 (2020) 567–581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Lo FC, Hsieh CC, Maestre-Reyna M, Chen CY, Ko TP, Horng YC, Lai YC, Chiang YW, Chou CM, Chiang CH, Huang WN, Lin YH, Bohle DS, Liaw WF, Crystal structure analysis of the repair of iron centers protein YtfE and its interaction with NO, Chemistry 22 (2016) 9768–9776. [DOI] [PubMed] [Google Scholar]
  • [22].Thompson JW, Salahudeen AA, Chollangi S, Ruiz JC, Brautigam CA, Makris TM, Lipscomb JD, Tomchick DR, Bruick RK, Structural and molecular characterization of iron-sensing hemerythrin-like domain within F-box and leucine-rich repeat protein 5 (FBXL5), J Biol Chem 287 (2012) 7357–7365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Ma Z, Strickland KT, Cherne MD, Sehanobish E, Rohde KH, Self WT, Davidson VL, The Rv2633c protein of Mycobacterium tuberculosis is a non-heme di-iron catalase with a possible role in defenses against oxidative stress, J Biol Chem 293 (2018) 1590–1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Alvarez-Carreno C, Becerra A, Lazcano A, Molecular evolution of the oxygen-binding hemerythrin domain, PLoS One 11 (2016) e0157904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Isaza CE, Silaghi-Dumitrescu R, Iyer RB, Kurtz DM Jr., Chan MK, Structural basis for O2 sensing by the hemerythrin-like domain of a bacterial chemotaxis protein: substrate tunnel and fluxional N terminus, Biochemistry 45 (2006) 9023–9031. [DOI] [PubMed] [Google Scholar]
  • [26].Ruiz JC, Bruick RK, F-box and leucine-rich repeat protein 5 (FBXL5): sensing intracellular iron and oxygen, J Inorg Biochem 133 (2014) 73–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Kendall JJ, Barrero-Tobon AM, Hendrixson DR, Kelly DJ, Hemerythrins in the microaerophilic bacterium Campylobacter jejuni help protect key iron-sulphur cluster enzymes from oxidative damage, Environ Microbiol 16 (2014) 1105–1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Kitanishi K, Igarashi J, Matsuoka A, Unno M, Identification and characterization of a redox sensor phosphodiesterase from Ferrovum sp. PN-J185 containing bacterial hemerythrin and HD-GYP domains, Biochemistry 59 (2020) 983–991. [DOI] [PubMed] [Google Scholar]
  • [29].Traverso ME, Subramanian P, Davydov R, Hoffman BM, Stemmler TL, Rosenzweig AC, Identification of a hemerythrin-like domain in a P1B-type transport ATPase, Biochemistry 49 (2010) 7060–7068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Seo JK, Nam BH, Go HJ, Jeong M, Lee KY, Cho SM, Lee IA, Park NG, Hemerythrin-related antimicrobial peptide, msHemerycin, purified from the body of the Lugworm, Marphysa sanguinea, Fish Shellfish Immunol 57 (2016) 49–59. [DOI] [PubMed] [Google Scholar]
  • [31].Galvez-Romero G, Salas-Rojas M, Hernandez GM, Blanco-Favela F, Aguilar-Setien A, Anti-baculovirus activity in a protein extracted from the exoskeleton of Pleuroncodes planipes [Decapoda: Galatheidae], Fish Shellfish Immunol 31 (2011) 482–484. [DOI] [PubMed] [Google Scholar]
  • [32].Coates CJ, Decker H, Immunological properties of oxygen-transport proteins: hemoglobin, hemocyanin and hemerythrin, Cell Mol Life Sci 74 (2017) 293–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Rodriguez-Celma J, Chou H, Kobayashi T, Long TA, Balk J, Hemerythrin E3 ubiquitin ligases as negative regulators of iron homeostasis in plants, Frony Plant Sci 10 (2019) 98–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Salahudeen AA, Thompson JW, Ruiz JC, Ma H-W, Kinch LN, Li Q, Grishin NV, Bruick RK, An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis, Science 326 (2009) 722–726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Wu WD, Wang M, Ding HH, Qiu ZJ, FBXL5 attenuates RhoGDI2-induced cisplatin resistance in gastric cancer cells, Eur Rev Med Pharmacol Sci 20 (2016) 2551–2557. [PubMed] [Google Scholar]
  • [36].Padmaja N, Rajaram H, Apte SK, A novel hemerythrin DNase from the nitrogen-fixing cyanobacterium Anabaena sp. strain PCC7120, Arch Biochem Biophys 505 (2011) 171–177. [DOI] [PubMed] [Google Scholar]
  • [37].deMare F, Kurtz DM Jr., Nordlund P, The structure of Desulfovibrio vulgaris rubrerythrin reveals a unique combination of rubredoxin-like FeS4 and ferritin-like diiron domains, Nat Struct Biol 3 (1996) 539–546. [DOI] [PubMed] [Google Scholar]
  • [38].Pierik AJ, Wolbert RB, Portier GL, Verhagen MF, Hagen WR, Nigerythrin and rubrerythrin from Desulfovibrio vulgaris each contain two mononuclear iron centers and two dinuclear iron clusters, Eur J Biochem 212 (1993) 237–245. [DOI] [PubMed] [Google Scholar]
  • [39].LeGall J, B.C. P, Moura I, Xavier AV, J.J.G. M, Hahn BH, Isolation and characterization of rubrerythrin, a non-heme iron protein from Desulfovibrio vulgaris that contains rubredoxin centers and a hemerythrin-like binuclear iron cluster, Biochemistry 27 (1988) 1636–1642. [DOI] [PubMed] [Google Scholar]
  • [40].Dillard BD, Demick JM, Adams MWW, Lanzilotta WN, A cryo-crystallographic time course for peroxide reduction by rubrerythrin from Pyrococcus furiosus, J Biol Inorg Chem 16 (2011) 949–959. [DOI] [PubMed] [Google Scholar]
  • [41].Li M, Liu M.-y., LeGall J, Gui L.-l., Liao J, Jiang T, Zhang J.-p., Liang D.-c., Chang W.-r., Crystal structure studies on rubrerythrin: enzymatic activity in relation to the zinc movement, J Biol Inorg Chem 8 (2003) 149–155. [DOI] [PubMed] [Google Scholar]
  • [42].Cabeza MS, Guerrero SA, Iglesias AA, Arias DG, New enzymatic pathways for the reduction of reactive oxygen species in Entamoeba histolytica, Biochim Biophys Acta 1850 (2015) 1233–1244. [DOI] [PubMed] [Google Scholar]
  • [43].Mishra S, Imlay J, Why do bacteria use so many enzymes to scavenge hydrogen peroxide?, Arch Biochm Biophys 525 (2012) 145–160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Kurtz DM Jr., Avoiding high-valent iron intermediates: superoxide reductase and rubrerythrin, J Inorg Biochem 100 (2006) 679–693. [DOI] [PubMed] [Google Scholar]
  • [45].Coulter ED, Kurtz DM Jr., A role for rubredoxin in oxidative stress protection in Desulfovibrio vulgaris: catalytic electron transfer to rubrerythrin and two-iron superoxide reductase, Arch Biochm Biophys 394 (2001) 76–86. [DOI] [PubMed] [Google Scholar]
  • [46].Riebe O, Fischer R-J, Wampler DA, Kurtz DM, Bahl H, Pathway for H2O2 and O2 detoxification in Clostridium acetobutylicum, Microbiology 155 (2009) 16–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Iyer RB, Silaghi-Dumitrescu R, Kurtz DM Jr., Lanzilotta WN, High-resolution crystal structures of Desulfovibrio vulgaris (Hildenborough) nigerythrin: facile, redox-dependent iron movement, domain interface variability, and peroxidase activity in the rubrerythrins, J Biol Inorg Chem 10 (2005) 407–416. [DOI] [PubMed] [Google Scholar]
  • [48].Folgosa F, Martins MC, Teixeira M, Diversity and complexity of flavodiiron NO/O2 reductases, FEMS Microbiol Lett 365 (2017). [DOI] [PubMed] [Google Scholar]
  • [49].Gomes CM, Giuffre A, Forte E, Vicente JB, Saraiva LM, Brunori M, Teixeira M, A novel type of nitric-oxide reductase. Escherichia coli flavorubredoxin, J Biol Chem 277 (2002) 25273–25276. [DOI] [PubMed] [Google Scholar]
  • [50].Baptista JM, Justino MC, Melo AM, Teixeira M, Saraiva LM, Oxidative stress modulates the nitric oxide defense promoted by Escherichia coli flavorubredoxin, J Bacteriol 194 (2012) 3611–3617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Petoukhov MV, Vicente JB, Crowley PB, Carrondo MA, Teixeira M, Svergun DI, Quaternary structure of flavorubredoxin as revealed by synchrotron radiation small-angle x-ray scattering, Structure 16 (2008) 1428–1436. [DOI] [PubMed] [Google Scholar]
  • [52].Romao CV, Vicente JB, Borges PT, Victor BL, Lamosa P, Silva E, Pereira L, Bandeiras TM, Soares CM, Carrondo MA, Turner D, Teixeira M, Frazao C, Structure of Escherichia coli flavodiiron nitric oxide reductase, J Mol Biol 428 (2016) 4686–4707. [DOI] [PubMed] [Google Scholar]
  • [53].Vicente JB, Scandurra FM, Rodrigues JV, Brunori M, Sarti P, Teixeira M, Giuffre A, Kinetics of electron transfer from NADH to the Escherichia coli nitric oxide reductase flavorubredoxin, FEBS J 274 (2007) 677–686. [DOI] [PubMed] [Google Scholar]
  • [54].Torrents E, Ribonucleotide reductases: essential enzymes for bacterial life, Front Cell. Infect Microbiol 4 (2014) 52–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Greene BL, Kang G, Cui C, Bennati M, Nocera DG, Drennan CL, Stubbe J, Ribonucleotide reductases: structure, chemistry, and metabolism suggest new therapeutic targets, Annu Rev Biochem 89 (2020) 45–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Chen P, Wu J-N, Shu Y, Jiang H-G, Zhao X-H, Qian H, Chen K, Lan T, Chen C-G, Li J, Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction, Clin Sci 132 (2018) 1417–1433. [DOI] [PubMed] [Google Scholar]
  • [57].Long MJC, Zhao Y, Aye Y, Clofarabine commandeers the RNR-α-ZRANB3 nuclear signaling axis, Cell Chem Biol 27 (2020) 122–133.e125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Wisitpitthaya S, Zhao Y, Long MJC, Li M, Fletcher EA, Blessing WA, Weiss RS, Aye Y, Cladribine and fludarabine nucleotides induce distinct hexamers defining a common mode of reversible RNR inhibition, ASC Chem Biol 11 (2016) 2021–2032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [59].Högbom M, Galander M, Andersson M, Kolberg M, Hofbauer W, Lassmann G, Nordlund P, Lendzian F, Displacement of the tyrosyl radical cofactor in ribonucleotide reductase obtained by single-crystal high-field EPR and 1.4-A x-ray data, Proc Natl Acad Sci USA 100 (2003) 3209–3214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Uppsten M, Färnegårdh M, Domkin V, Uhlin U, The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action, J Mol Biol 359 (2006) 365–377. [DOI] [PubMed] [Google Scholar]
  • [61].Kang G, Taguchi AT, Stubbe J, Drennan CL, Structure of a trapped radical transfer pathway within a ribonucleotide reductase holocomplex, Science 368 (2020) 424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [62].Nick TU, Lee W, Koßmann S, Neese F, Stubbe J, Bennati M, Hydrogen bond network between amino acid radical intermediates on the proton-coupled electron transfer pathway of E. coli α2 ribonucleotide reductase, J Am Chem Soc 137 (2015) 289–298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Ravichandran K, Olshansky L, Nocera DG, Stubbe J, Subunit Interaction Dynamics of Class Ia Ribonucleotide Reductases: In Search of a Robust Assay, Biochemistry 59 (2020) 1442–1453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Saleh L, Bollinger JM Jr., Cation mediation of radical transfer between Trp48 and Tyr356 during O2 activation by protein R2 of Escherichia coli ribonucleotide reductase: relevance to R1-R2 radical transfer in nucleotide reduction?, Biochemistry 45 (2006) 8823–8830. [DOI] [PubMed] [Google Scholar]
  • [65].Bollinger JM, Tong WH, Ravi N, Huynh BH, Edmonson DE, Stubbe J, Mechanism of assembly of the tyrosyl radical-diiron(iii) cofactor of E. coli ribonucleotide reductase. 2. Kinetics of the excess Fe2+ reaction by optical, EPR, and Moessbauer spectroscopies, J Am Chem Soc 116 (1994) 8015–8023. [Google Scholar]
  • [66].Greene BL, Stubbe J, Nocera DG, Selenocysteine substitution in a class i ribonucleotide reductase, Biochemistry 58 (2019) 5074–5084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Rosenzweig AC, Frederick SJ Fau - Lippard Ca, Lippard P Fau - Nordlund Sj, Nordlund P, Crystal structure of a bacterial non-haem iron hydroxylase that catalyses the biological oxidation of methane, Nature 366 (1993) 537–543. [DOI] [PubMed] [Google Scholar]
  • [68].Merkx M, Kopp DA, Sazinsky MH, Blazyk JL, Muller J, Lippard SJ, Dioxygen activation and methane hydroxylation by soluble methane monooxygenase: A tale of two irons and three proteins Angew. Chem., Int. Ed. Engl 40 (2001) 2782–2807. [DOI] [PubMed] [Google Scholar]
  • [69].Lee SJ, McCormick MS, Lippard SJ, Cho U-S, Control of substrate access to the active site in methane monooxygenase, Nature 494 (2013) 380–384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Merkx M, Lippard SJ, Why OrfY? Characterization of MMOD, a long overlooked component of the soluble methane monooxygenase from Methylococcus capsulatus (Bath), J Biol Chem 277 (2002) 5858–5865. [DOI] [PubMed] [Google Scholar]
  • [71].Kim H, An S, Park YR, Jang H, Yoo H, Park SH, Lee SJ, Cho U-S, MMOD-induced structural changes of hydroxylase in soluble methane monooxygenase, Science advances 5 (2019) eaax0059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [72].Kal S, Que L Jr., Activation of a non-heme Fe(III) -OOH by a second Fe(III) to hydroxylate strong C-H bonds: Possible implications for soluble methane monooxygenase, Angew. Chem., Int. Ed. Engl 58 (2019) 8484–8488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [73].Kass D, Corona T, Warm K, Braun-Cula B, Kuhlmann U, Bill E, Mebs S, Swart M, Dau H, Haumann M, Hildebrandt P, Ray K, Stoichiometric formation of an oxoiron(IV) complex by a soluble methane monooxygenase type activation of O2 at an Iron(II)-cyclam center, J Am Chem Soc 142 (2020) 5924–5928. [DOI] [PubMed] [Google Scholar]
  • [74].Ross MO, Rosenzweig AC, A tale of two methane monooxygenases, J Biol Inorg Chem 22 (2017) 307–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [75].Muhoberac BB, Vidal R, Iron, ferritin, hereditary ferritinopathy, and neurodegeneration, Front Neurosci 13 (2019) 1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Bertini I, Lalli D, Mangani S, Pozzi C, Rosa C, Theil EC, Turano P, Structural insights into the ferroxidase site of ferritins from higher eukaryotes, J Am Chem Soc 134 (2012) 6169–6176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [77].Sato D, Ikeguchi M, Mechanisms of ferritin assembly studied by time-resolved small-angle X-ray scattering, Biophys Rev 11 (2019) 449–455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Bellini M, Riva B, Tinelli V, Rizzuto MA, Salvioni L, Colombo M, Mingozzi F, Visioli A, Marongiu L, Frascotti G, Christodoulou MS, Passarella D, Prosperi D, Fiandra L, Engineered ferritin nanoparticles for the bioluminescence tracking of nanodrug delivery in cancer, Small (2020) e2001450. [DOI] [PubMed] [Google Scholar]
  • [79].Liu Y, Yang R, Liu J, Meng D, Zhou Z, Zhang Y, Blanchard C, Fabrication, structure, and function evaluation of the ferritin based nano-carrier for food bioactive compounds, Food Chem 299 (2019) 125097–125097. [DOI] [PubMed] [Google Scholar]
  • [80].Wang Y, Chen J Fau - Zang H, Zang X Fau - Zhang J, Zhang G Fau - Zhao X, Zhao G, Re-designing ferritin nanocages for mercuric ion detection, The Analyst 144 (2019) 5890–5897. [DOI] [PubMed] [Google Scholar]
  • [81].Pozzi C, Ciambellotti S, Bernacchioni C, Di Pisa F, Mangani S, Turano P, Chemistry at the protein-mineral interface in L-ferritin assists the assembly of a functional (mu(3)-oxo)Tris[(mu(2)-peroxo)] triiron(III) cluster, Proc Natl Acad Sci U S A 114 (2017) 2580–2585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [82].Pozzi C, Di Pisa F, Bernacchioni C, Ciambellotti S, Turano P, Mangani S, Iron binding to human heavy-chain ferritin, Acta Crystallogr. D. 71 (2015) 1909–1920. [DOI] [PubMed] [Google Scholar]
  • [83].Tatur J, Hagen WR, Heering HA, Voltammetry of Pyrococcus furiosus ferritin: dependence of iron release rate on mediator potential, Dalton Trans (2009) 2837–2842. [DOI] [PubMed] [Google Scholar]
  • [84].Tatur J, Hagen WR, Matias PM, Crystal structure of the ferritin from the hyperthermophilic archaeal anaerobe Pyrococcus furiosus, J Biol Inorg Chem 12 (2007) 615–630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Ha Y, Shi D, Small GW, Theil EC, Allewell NM, Crystal structure of bullfrog M ferritin at 2.8 A resolution: analysis of subunit interactions and the binuclear metal center, J Biol Inorg Chem 4 (1999) 243–256. [DOI] [PubMed] [Google Scholar]
  • [86].Trikha J, Theil EC, Allewell NM, High resolution crystal structures of amphibian red-cell L ferritin: potential roles for structural plasticity and solvation in function, J Mol Biol 248 (1995) 949–967. [DOI] [PubMed] [Google Scholar]
  • [87].Cho KJ, Shin HJ, Lee J-H, Kim K-J, Park SS, Lee Y, Lee C, Park SS, Kim KH, The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake, J Mol Biol 390 (2009) 83–98. [DOI] [PubMed] [Google Scholar]
  • [88].Honarmand Ebrahimi K, Hagedoorn PL, Hagen WR, Unity in the biochemistry of the iron-storage proteins ferritin and bacterioferritin, Chem. Rev. 115 (2015) 295–326. [DOI] [PubMed] [Google Scholar]
  • [89].Honarmand Ebrahimi K, Bill E, Hagedoorn PL, Hagen WR, The catalytic center of ferritin regulates iron storage via Fe(II)-Fe(III) displacement, Nat Chem Biol 8 (2012) 941–948. [DOI] [PubMed] [Google Scholar]
  • [90].Bou-Abdallah F, Yang H, Awomolo A, Cooper B, Woodhall MR, Andrews SC, Chasteen ND, Functionality of the three-site ferroxidase center of Escherichia coli bacterial ferritin (EcFtnA), Biochemistry 53 (2014) 483–495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [91].Yao H, Jepkorir S Fau - Lovell G, Lovell PV au - Nama S, Nama S Fau - Weeratunga Pv, Weeratunga KP Fau - Battaile S, Battaile M Fau - Rivera Kp, Rivera M, Two distinct ferritin-like molecules in Pseudomonas aeruginosa: the product of the bfrA gene is a bacterial ferritin (FtnA) and not a bacterioferritin (Bfr), Biochemistry 50 (2011) 5236–5248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [92].Stillman TJ, Hempstead PD, Artymiuk PJ, Andrews SC, Hudson AJ, Treffry A, Guest JR, Harrison PM, The high-resolution X-ray crystallographic structure of the ferritin (EcFtnA) of Escherichia coli; comparison with human H ferritin (HuHF) and the structures of the Fe(3+) and Zn(2+) derivatives, J Mol Biol 307 (2001) 587–603. [DOI] [PubMed] [Google Scholar]
  • [93].Bou-Abdallah F, The iron redox and hydrolysis chemistry of the ferritins, Biochim Biophys Acta 1800 (2010) 719–731. [DOI] [PubMed] [Google Scholar]
  • [94].Kim S, Lee JH, Seok JH, Park YH, Jung SW, Cho AE, Lee C, Chung MS, Kim KH, Structural basis of novel iron-uptake route and reaction intermediates in ferritins from gram-negative bacteria, J Mol Biol 428 (2016) 5007–5018. [DOI] [PubMed] [Google Scholar]
  • [95].Williams SM, Chatterji D, An Overview of Dps: Dual acting nanovehicles in prokaryotes with DNA binding and ferroxidation properties, Subcell Biochem 96 (2021) 177–216. [DOI] [PubMed] [Google Scholar]
  • [96].Haikarainen T, Papageorgiou AC, Dps-like proteins: structural and functional insights into a versatile protein family, Cell. Mol Life Sci 67 (2010) 341–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [97].Chiancone E, Ceci P, The multifaceted capacity of Dps proteins to combat bacterial stress conditions: Detoxification of iron and hydrogen peroxide and DNA binding, Biochim Biophys Acta 1800 (2010) 798–805. [DOI] [PubMed] [Google Scholar]
  • [98].Arnold AR, Zhou A, Barton JK, Characterization of the DNA-mediated oxidation of dps, a bacterial ferritin, J Am Chem Soc 138 (2016) 11290–11298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [99].Ceci P, Cellai S, Falvo E, Rivetti C, Rossi GL, Chiancone E, DNA condensation and self-aggregation of Escherichia coli Dps are coupled phenomena related to the properties of the N-terminus, Nucleic Acids Res 32 (2004) 5935–5944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [100].Ekman M, Sandh G, Nenninger A, Oliveira P, Stensjo K, Cellular and functional specificity among ferritin-like proteins in the multicellular cyanobacterium Nostoc punctiforme, Environ Microbiol 16 (2014) 829–844. [DOI] [PubMed] [Google Scholar]
  • [101].Mohanty A, Subhadarshanee B, Barman P, Mahapatra C, Aishwarya B, Behera RK, Iron mineralizing bacterioferritin A from Mycobacterium tuberculosis exhibits unique catalase-Dps-like dual activities, Inorg Chem 58 (2019) 4741–4752. [DOI] [PubMed] [Google Scholar]
  • [102].Rivera M, Bacterioferritin: structure, dynamics, and protein-protein interactions at play in iron storage and mobilization, Acc Chem Res 50 (2017) 331–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [103].Crow A, Lawson TL, Lewin A, Moore GR, Le Brun NE, Structural basis for iron mineralization by bacterioferritin, J Am Chem Soc 131 (2009) 6808–6813. [DOI] [PubMed] [Google Scholar]

RESOURCES